← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lamassu Pharma Inc.
Durham, NC
$3,317,651
Total funding
1
Grants
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,317,651 · 1
By mechanism
R44$3,317,651 · 1
Investigators at Lamassu Pharma Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of a novel lipase inhibitor for the treatment of acute pancreatitis$1,498,822
R44 · FY2020 · DK
One Health Advancement of RABI-767 for the Management of Acute Pancreatitis$873,744
R44 · FY2024 · DK
One Health Advancement of RABI-767 for the Management of Acute Pancreatitis$866,665
R44 · FY2025 · DK
Development of a novel lipase inhibitor for the treatment of acute pancreatitis$78,420
R44 · FY2021 · DK